Natus Medical (BABY) Tops Q4 EPS by 5c; Guides Q1, FY16

Natus Medical (NASDAQ: BABY) reported Q4 EPS of $0.51, $0.05 better than the analyst estimate of $0.46. Revenue for the quarter came in at $100 million versus the consensus estimate of $100.1 million.

GUIDANCE:

Natus Medical sees Q1 2016 EPS of $0.34-$0.35, versus the consensus of $0.34. Natus Medical sees Q1 2016 revenue of $96.5-97.5 million, versus the consensus of $96.9 million.

Natus Medical sees FY2016 EPS of $1.84-$1.88, versus the consensus of $1.85. Natus Medical sees FY2016 revenue of $445-450 million, versus the consensus of $446.5 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Marpai, Inc. (MRAI) Misses Q2 EPS by 18c